Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dendreon
Dendreon
Speculative Biotech For The Iron-Stomached
Seeking Alpha
Fri, 03/9/12 - 10:53 am
Geron
Keryx
Dendreon
Advanced Cell Technology
Aeterna Zentaris
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
Immunocellular Thereapeutics: Pending Catalysts Could Spark Share Price Run
Seeking Alpha
Mon, 03/5/12 - 11:48 am
ImmunoCellular
Celgene
Dendreon
Oncothyreon
Teva Pharmaceuticals
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Mon, 03/5/12 - 11:13 am
Dendreon
Provenge
prostate cancer
Celldex
Agenus
Cel-Sci
ImmunoCellular
Dendreon Posts 4th-Quarter Profit on Royalty Stream Sale, Provenge
WSJ Online
Mon, 02/27/12 - 05:06 pm
earnings
Dendreon
Provenge
How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch
Minyanville
Fri, 02/24/12 - 10:02 am
earnings
Dendreon
Agenus
Galena Biopharma
ImmunoCellular
Forbes Earnings Preview: Dendreon
Forbes
Wed, 02/22/12 - 11:01 am
Dendreon
earnings
Dendreon: Overall Survival Data For Provenge From 2012 GU Poster
Seeking Alpha
Fri, 02/17/12 - 01:15 pm
Dendreon
prostate cancer
Provenge
Selling Drugs: Small Biotech Stocks With Strong Sales Growth
Seeking Alpha
Tue, 02/14/12 - 11:21 am
AstraZeneca
Cephalon
Dendreon
Forest Labs
Human Genome Sciences
Jazz Pharmaceuticals
Pfizer
Teva Pharmaceuticals
Spectrum Pharmaceuticals
New CEO = Dendreon Takeover Target?
Motley Fool
Thu, 02/2/12 - 10:09 am
Dendreon
M&A
Pharma CEOs
Savient
John Johnson
Dendreon And Provenge's True Median Life-Extension Benefit
Seeking Alpha
Wed, 02/1/12 - 11:36 am
prostate cancer
Provenge
Dendreon
Why CEO Replacement Is Good News For Dendreon
Forbes
Wed, 02/1/12 - 11:30 am
Dendreon
Pharma CEOs
Mitchell Gold
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Seeking Alpha
Tue, 01/31/12 - 07:47 am
Dendreon
Provenge
prostate cancer
JNJ
Zytiga
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
BioDelivery Sciences
Biovest International
Celldex
MannKind
NovaBay Pharmaceuticals
Keryx
ImmunoCellular
Cel-Sci
Dendreon
Generex
Human Genome Sciences
Another Revival Could Be In Store For Immunocellular Therapeutics
Seeking Alpha
Wed, 01/18/12 - 09:51 am
ImmunoCellular Therapeutics
Dendreon
Dendreon: Following Up On Market Mania
Seeking Alpha
Tue, 01/17/12 - 06:49 pm
Dendreon
prostate cancer
Provenge
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
SOMA
Regeneron
Vertex
Gilead
GSK
Biocryst
Dendreon
InterMune
Biotechs: Has The Law Of Gravity Been Suspended?
Seeking Alpha
Sat, 01/14/12 - 11:27 am
Celgene
Dendreon
Medivation
Regeneron
ViroPharma
11 Biotech Bets For 2012
Seeking Alpha
Thu, 01/12/12 - 10:16 pm
Zalicus
Teva Pharmaceuticals
Spectrum
Astex
Aeterna Zentaris
Cel-Sci
Dendreon
Keryx
NPS Pharmaceuticals
Pharmacyclics
Questcor
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Celldex
Amgen
Bristol-Myers Squibb
Dendreon
Seattle Genetics
Exelixis
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »